Cosciens Biopharma deregisters common shares with SEC, ends US reporting obligationsPUBT·Jul 6 at 03:31 PMCSCI0.00%CSCIF-6.04%
COSCIENS Biopharma Inc. Completes Share Capital Amendment | CSCIF Stock NewsStockTitan·Jul 2 at 11:30 PMCSCIF-6.04%CSCI0.00%
Cosciens Biopharma shareholders approve share capital amendment at annual meetingPUBT·Jun 18 at 07:30 AMCSCI0.00%CSCIF-6.04%
COSCIENS Biopharma Inc. Reports Q1 2026 Results | CSCIF Stock NewsStockTitan·May 12 at 08:05 AMCSCIF-6.04%CSCI0.00%
COSCIENS Biopharma Seeks Approval for Share Capital Restructuring and Virtual AGM in June 2026Tip Ranks·Apr 20 at 07:29 AMCSCI0.00%CSCIF-6.04%
COSCIENS Comments on Unusual Market Activity | CSCIF Stock NewsStockTitan·Apr 7 at 08:10 AMPBE0.00%IHI-1.03%
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | CSCIF Stock NewsStockTitan·Mar 25 at 08:05 AMSBIO-0.26%XLV-0.89%
COSCIENS Provides Strategic Update | CSCIF Stock NewsStockTitan·Mar 5 at 08:10 AMCSCIF-6.04%CSCI0.00%
